Skip to main content
. Author manuscript; available in PMC: 2018 Jan 20.
Published in final edited form as: Genet Med. 2017 Jul 20;20(1):119–127. doi: 10.1038/gim.2017.85

Table 1.

Clinical and demographic characteristics, total and by FPC status

Total (n=302) FPC (n=185) Familial non-FPC (n=117)
Median age at PDAC (range) 65 (37–93) 66 (37–93) 64 (38–87)

N % N % N %

Sex, male 162 53.5 98 53.0 64 54.7
Race
 White 293 97.7 180 98.4 113 96.6
 African American 4 1.3 3 1.6 1 0.9
 American Indian/Alaska Native 1 0.3 0 0 1 0.9
 Native Hawaiian 1 0.3 0 0 1 0.9
 Multiracial 1 0.3 0 0 1 0.9
 Missing 2 - 2 - 0 -
Ethnicity
 Non-Hispanic/non-Latino 291 99.7 176 100 115 99.1
 Hispanic/Latino 1 0.3 0 0 1 0.9
 Missing 10 - 9 - 1 -
Ashkenazi Jewish heritage
 No 288 97.3 173 95.6 115 100
 Yes 8 2.7 8 4.4 0 0
 Missing 6 - 4 - 2 -
Number PDAC per kindred
 2 239 79.2 128 69.2 111 94.9
 3 44 14.6 38 20.5 6 5.1
 4+ 19 6.2 19 10.2 0 0
PDAC stage
 Resectable 88 31.7 48 29.1 40 35.4
 Locally advanced 77 27.7 46 27.9 31 27.4
 Metastatic 113 40.6 71 43.0 42 37.2
 Missing 24 20 - 4 -